Pitfalls in Patch Testing: Minimizing the Risk of Avoidable False-Negative Reactions.

Allergens / immunology Bias Dermatitis, Allergic Contact / diagnosis Diagnostic Errors / prevention & control False Negative Reactions Humans Patch Tests / adverse effects Practice Guidelines as Topic
Allergic contact dermatitis False-negative Patch testing

Journal

Dermatologic clinics
ISSN: 1558-0520
Titre abrégé: Dermatol Clin
Pays: United States
ID NLM: 8300886

Informations de publication

Date de publication:
Jul 2020
Historique:
entrez: 2 6 2020
pubmed: 2 6 2020
medline: 9 3 2021
Statut: ppublish

Résumé

Patch testing is the gold-standard diagnostic tool for the diagnosis of allergic contact dermatitis; unfortunately, it is a procedure with potential for errors, including false-negative reactions. Some of the factors responsible for this are likely unavoidable; however, others may potentially lie within the control of the user. Knowledge and management of these controllable factors may improve the outcome of patch testing and minimize the incidence of false-negative patch test results.

Identifiants

DOI: 10.1016/j.det.2020.02.007 PMID: 32475507
pubmed: 32475507
pii: S0733-8635(20)30017-6
doi: 10.1016/j.det.2020.02.007
pii:
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-300

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Solveig Ophaug (S)

Department of Dermatology, Oregon Health and Science University, 3303 SW Bond Avenue, CH16D, Portland, OR 97239, USA.

Kathryn Schwarzenberger (K)

Department of Dermatology, Oregon Health and Science University, 3303 SW Bond Avenue, CH16D, Portland, OR 97239, USA. Electronic address: schwarka@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Antigènes › Allergènes › Pitfalls in Patch Testing: Minimizing the Risk...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Biais (épidémiologie) › Pitfalls in Patch Testing: Minimizing the Risk...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité retardée › Eczéma de contact allergique › Pitfalls in Patch Testing: Minimizing the Risk...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Erreurs médicales › Erreurs de diagnostic › Pitfalls in Patch Testing: Minimizing the Risk...
questionsmedicales.fr › Diagnostic › Faux négatifs › Pitfalls in Patch Testing: Minimizing the Risk...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Pitfalls in Patch Testing: Minimizing the Risk...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Tests cutanés › Tests épicutanés › Pitfalls in Patch Testing: Minimizing the Risk...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Pitfalls in Patch Testing: Minimizing the Risk...